MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Treatment induced psychogenic movement disorders: a case series

    V. Palakuzhy, S. Anderson, N. Patel (Chicago, USA)

  • Treatment of chorea in pediatric subjects with pallidal and thalamic deep brain stimulation

    J. Maclean, A. Salisbury, J. Olaya, M. Liker, T. Sanger (Orange, USA)

  • TREM2 maintain microglial proliferation and α-syn accumulation in PD models via the PI3K-Akt pathway

    S. Yin, Y. Xia, F. Wan, L. Kou, T. Wang (Wuhan, China)

  • Tremor characteristics differentially respond to levodopa and subthalamic nucleus deep brain stimulation in Parkinson’s disease

    T. Wirth, F. Ferreira, N. Vijiaratnam, C. Girges, A. Pakzad, A. Roquemaurel, O. Sinani, J. Hyam, M. Hariz, L. Zrinzo, H. Akram, P. Limousin, T. Foltynie (Strasbourg, France)

  • Tremor characteristics in patients with chronic inflammatory demyelinating polyneuropathy

    G. Pallada, SEM. Ten Holter, F. Eftimov, RMA. de Bie, JM. Dijk, AF. van Rootselaar (Amsterdam, Netherlands)

  • Tremor in patients with chronic inflammatory demyelinating polyneuropathy: prevalence and severity

    G. Pallada, SEM. Ten Holter, F. Eftimov, RMA. de Bie, AF. van Rootselaar, JM. Dijk (Amsterdam, Netherlands)

  • Tremor Reduction Using DBS: Outcomes of a Real-world, Prospective, Multicenter Essential Tremor Registry

    G. Deuschl, G. Loret, N. Kovacs, M. Blázquez Estrada, F. Clement, J. Lee, P. Schuurman, S. Delvaux, L. Chen, R. Jain (Kiel, Germany)

  • Tremors and More: A Case Report of TBK1 Mutation and Electrophysiological Assessment

    B. Elahi (Maywood, USA)

  • Trends in the evaluation and management of constipation in patients with Parkinson disease

    L. Deuel, W. Wright, E. Houston (Burlington, USA)

  • Trial protocol: Randomized double blind controlled study to investigate disease modifying effect, safety and optimal dose of oral semaglutide tablet for patients with Parkinson’s disease (MOST-ABLE study)

    Y. Kimura, T. Koda, H. Kurakami, S. Sakamoto, K. Iwasaki, H. Mochizuki (Suita, Osaka, Japan)

  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley